BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25454978)

  • 21. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
    Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
    J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
    Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE
    Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tgfbr1 haploinsufficiency inhibits the development of murine mutant Kras-induced pancreatic precancer.
    Adrian K; Strouch MJ; Zeng Q; Barron MR; Cheon EC; Honasoge A; Xu Y; Phukan S; Sadim M; Bentrem DJ; Pasche B; Grippo PJ
    Cancer Res; 2009 Dec; 69(24):9169-74. PubMed ID: 19951995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.
    Hidalgo-Sastre A; Brodylo RL; Lubeseder-Martellato C; Sipos B; Steiger K; Lee M; von Figura G; Grünwald B; Zhong S; Trajkovic-Arsic M; Neff F; Schmid RM; Siveke JT
    Am J Pathol; 2016 Nov; 186(11):2934-2944. PubMed ID: 27639167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells.
    Ischenko I; Petrenko O; Hayman MJ
    Oncotarget; 2015 Jun; 6(18):15814-27. PubMed ID: 26158412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
    Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y
    Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis.
    Flandez M; Cendrowski J; Cañamero M; Salas A; del Pozo N; Schoonjans K; Real FX
    Gut; 2014 Apr; 63(4):647-55. PubMed ID: 23598351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockout of 5-lipoxygenase results in age-dependent anxiety-like behavior in female mice.
    Joshi YB; Praticò D
    PLoS One; 2011; 6(12):e29448. PubMed ID: 22220211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium-dependent eicosanoid metabolism by concanavalin A-stimulated human monocytes in vitro. Synergism with phorbol ester indicates separate regulation of leukotriene B4 synthesis and release.
    Hoffman T; Brando C; Lizzio EF; Lee YL; Hansen M; Tripathi AK; Taplits M; Puri J; Bonvini E; Abrahamsen TG
    J Immunol; 1991 Jan; 146(2):692-700. PubMed ID: 1846160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
    Zhao WG; Yu SN; Lu ZH; Ma YH; Gu YM; Chen J
    Carcinogenesis; 2010 Oct; 31(10):1726-33. PubMed ID: 20675343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model.
    Siddique HR; Liao DJ; Mishra SK; Schuster T; Wang L; Matter B; Campbell PM; Villalta P; Nanda S; Deng Y; Saleem M
    Int J Cancer; 2012 Oct; 131(7):1720-31. PubMed ID: 22190076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophils recruited by leukotriene B4 induce features of plaque destabilization during endotoxaemia.
    Mawhin MA; Tilly P; Zirka G; Charles AL; Slimani F; Vonesch JL; Michel JB; Bäck M; Norel X; Fabre JE
    Cardiovasc Res; 2018 Oct; 114(12):1656-1666. PubMed ID: 29800147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Mixture of Polyunsaturated Fatty Acids ω-3 and ω-6 Reduces Melanoma Growth by Inhibiting Inflammatory Mediators in the Murine Tumor Microenvironment.
    Almeida EB; Silva KPH; Paixão V; Amaral JBD; Rossi M; Xavier-Navarro RA; Barros KV; Silveira VLF; Vieira RP; Oliveira LVF; Perez EC; Jasiulionis MG; Bachi ALL
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31374840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma.
    Rao CV; Janakiram NB; Madka V; Devarkonda V; Brewer M; Biddick L; Lightfoot S; Steele VE; Mohammed A
    Oncotarget; 2015 Oct; 6(32):33290-305. PubMed ID: 26429877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
    Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired wound healing in type 1 diabetes is dependent on 5-lipoxygenase products.
    Ramalho T; Filgueiras L; Silva-Jr IA; Pessoa AFM; Jancar S
    Sci Rep; 2018 Sep; 8(1):14164. PubMed ID: 30242286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
    Xie F; Li C; Zhang X; Peng W; Wen T
    Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast cells and leukotrienes mediate neutrophil sequestration and lung edema after remote ischemia in rodents.
    Goldman G; Welbourn R; Klausner JM; Kobzik L; Valeri CR; Shepro D; Hechtman HB
    Surgery; 1992 Sep; 112(3):578-86. PubMed ID: 1325674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.